The miRNA signature associated to MYC has been characterized in cellular models [19], in liver cancer [24], in neuroblastoma [25], in lymphomas known to overexpress MYC such as Burkitt’s lymphoma and diffuse large B-cell lymphomas [26] and by computational methods [27]. This evidence concerns the gene MYC and Burkitt lymphoma.